expand/collapse risk warning

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

80% of retail investor accounts lose money when trading CFDs with this provider.

Regulator:

×
CySEC

Skilling Ltd, is regulated by the Cyprus Securities and Exchange Commission (CySEC) under CIF license No. 357/18

Continue
FSA

Skilling (Seychelles) Ltd, is authorized and regulated by the Financial Services Authority (FSA) under license No. SD042

Continue

Loading...

Pfizer stock chart

The most popular and up-and-rising shares.

[[ data.name ]]

[[ data.ticker ]]

[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)

Low: [[ data.low ]]

High: [[ data.high ]]

About

History

Differences between Investing vs Trading

About

History

Differences between Investing vs Trading

Pfizer is an American pharmaceutical company with a long and successful history. It was founded in 1849 by two German immigrants, Charles Pfizer and Charles Erhardt. The company went public in 1963 and has since become one of the largest pharmaceutical companies in the world. Pfizer's products include some of the most well-known and trusted brands in the industry, such as Advil, Viagra, and Lipitor. In recent years, Pfizer has been working to expand its product line beyond traditional medications and into areas such as vaccines and cancer treatments.

The Covid-19 pandemic has presented both challenges and opportunities for Pfizer. On the one hand, the company's factories have been working around the clock to produce vaccines and other treatments for the disease. On the other hand, many of Pfizer's products are used to treat conditions that have become more common during the pandemic, such as anxiety and depression. As a result, Pfizer's sales and profits have been strong in recent years.

Pfizer's share price has been on a rollercoaster ride over the past few years. After hitting an all-time high in early 2020, the stock plunged in the wake of the Covid-19 pandemic. However, Pfizer has since staged a strong recovery and its share price is now back near its pre-pandemic highs.

Looking ahead, Pfizer's share price is likely to be influenced by a number of factors, including the company's ongoing efforts to develop new medicines, competition from other drugmakers like Johnson & Johnson, Merck, and Novartis as well as global economic conditions.

Pfizer, Moderna and AstraZeneca are all big names in the pharmaceutical industry. Pfizer’s stock price has outperformed the market in the last 5 years. Moderna’s stock price has exploded in the last few years but is still down from its highs. AstraZeneca’s stock price has lagged the market over the last 5 years. If you're looking for a large-cap pharmaceutical stock Pfizer could be worth considering.

Investing in Pfizer stock CFDs allows you to speculate on the price movements of the underlying asset without actually owning the shares. This means that you can take a long or short position, depending on your market forecast. Trading Pfizer stock CFDs is a leveraged product, which means that you only need to put down a small deposit (margin) to open a much larger trade. This gives you the potential to make large profits, but also comes with increased risk. Please note that CFD trading involves a significant risk of loss.

When investing in Pfizer shares, you will be buying and selling the actual shares of the company. This means that if the share price goes up, you will make a profit, and if it goes down, you will make a loss. With CFD trading, you are speculating on the price movements of the underlying asset, without actually owning it. This means that you can take a long or short position, depending on your market forecast.

Loading
Swap long [[ data.swapLong ]] points
Swap short [[ data.swapShort ]] points
Spread min [[ data.stats.minSpread ]]
Spread avg [[ data.stats.avgSpread ]]
Min contract size [[ data.minVolume ]]
Min step size [[ data.stepVolume ]]
Commission and Swap Commission and Swap
Leverage Leverage
Trading Hours Trading Hours

* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.

device-default.png

Trade [[data.name]] with Skilling

All Hassle-free, with flexible trade sizes and with zero commissions!*

  • Trade 24/5
  • Minimum margin requirements
  • No commission, only spread
  • Fractional shares available
  • Easy to use platform

*Other fees may apply.

Sign up

FAQs

Which are the competitors of Pfizer shares?

+ -

The main competitors of Pfizer shares are Johnson & Johnson, Merck & Co., and GlaxoSmithKline. These companies are all large pharmaceutical firms with a significant presence in the global market. Each of these companies has a strong portfolio of drugs and a long history of success in the industry. They are all well-positioned to compete with Pfizer in the future.

Who owns most Pfizer shares?

+ -

The majority of Pfizer shares are owned by institutional investors, such as mutual funds and pension funds. However, a significant number of shares are also owned by individual investors. According to Pfizer's most recent annual report, the top 10 shareholders (excluding insiders) own approximately 28% of the company's outstanding shares.

Some of the largest institutional investors in Pfizer include Vanguard Group, BlackRock, Fidelity Investments, and State Street Corporation. However, there are many other large institutional investors that own significant stakes in the company.

Do Pfizer shares pay dividends?

+ -

The company has a long history of paying dividends to shareholders, and currently offers a dividend yield of approximately 3.5%. However, it is important to note that Pfizer's dividend payout ratio is quite high, at nearly 80%. This means that the company is paying out a large portion of its earnings as dividends, and may not have much room to increase its dividend in the future.

Why Trade [[data.name]]

Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.

CFDs
Equities
chart-long.svg

Capitalise on rising prices (go long)

green-check-ico.svg
green-check-ico.svg
chart-short.svg

Capitalise on falling prices (go short)

green-check-ico.svg
leverage-ico.svg

Trade with leverage
Hold larger positions than the cash you have at your disposal

green-check-ico.svg
trade-ico.svg

Trade on volatility
No need to own the asset

green-check-ico.svg
commissions-ico.svg

No commissions
Just low spreads

green-check-ico.svg
risk-ico.svg

Manage risk with in-platform tools
Ability to set take profit and stop loss levels

green-check-ico.svg

Important notice

This page/website is not directed to EU clients and falls outside the European regulatory framework and is not in the scope of (among others) the Markets in Financial Instruments Directive (MiFID) II.
By continuing you acknowledge to view the content provided by Skilling (Seychelles) Limited, which is authorised and regulated by Seychelles Financial Supervisory Authority, and that your decision was made independently and at your exclusive initiative and no solicitation or recommendation has been made by Skilling or any other entity within the group.

Continue

Important notice

This page/website is not directed to EU clients and falls outside the European regulatory framework and is not in the scope of (among others) the Markets in Financial Instruments Directive (MiFID) II.
By continuing you acknowledge to view the content provided by Skilling (Seychelles) Limited, which is authorised and regulated by Seychelles Financial Supervisory Authority, and that your decision was made independently and at your exclusive initiative and no solicitation or recommendation has been made by Skilling or any other entity within the group.

Continue